Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia … JC Yam, Y Jiang, SM Tang, AKP Law, JJ Chan, E Wong, ST Ko, AL Young, ... Ophthalmology 126 (1), 113-124, 2019 | 650 | 2019 |
Ultraviolet light and ocular diseases JCS Yam, AKH Kwok International ophthalmology 34, 383-400, 2014 | 352 | 2014 |
Vulnerability and resilience in children during the COVID-19 pandemic WWY Tso, RS Wong, KTS Tung, N Rao, KW Fu, JCS Yam, GT Chua, ... European child & adolescent psychiatry, 1-16, 2020 | 309 | 2020 |
Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report JC Yam, FF Li, X Zhang, SM Tang, BHK Yip, KW Kam, ST Ko, AL Young, ... Ophthalmology 127 (7), 910-919, 2020 | 294 | 2020 |
IMI risk factors for myopia IG Morgan, PC Wu, LA Ostrin, JWL Tideman, JC Yam, W Lan, RC Baraas, ... Investigative ophthalmology & visual science 62 (5), 3-3, 2021 | 285 | 2021 |
Global retinoblastoma presentation and analysis by national income level ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ... JAMA oncology 6 (5), 685-695, 2020 | 274 | 2020 |
Ocular toxicity of hydroxychloroquine JCS Yam, AKH Kwok Hong Kong Medical Journal 12 (4), 294, 2006 | 248 | 2006 |
A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre CY Cheung, D Xu, CY Cheng, C Sabanayagam, YC Tham, M Yu, TH Rim, ... Nature biomedical engineering 5 (6), 498-508, 2021 | 169 | 2021 |
Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study X Zhang, SSL Cheung, HN Chan, Y Zhang, YM Wang, BH Yip, KW Kam, ... British Journal of Ophthalmology 106 (12), 1772-1778, 2022 | 139 | 2022 |
High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study JC Yam, SM Tang, KW Kam, LJ Chen, M Yu, AK Law, BH Yip, YM Wang, ... Acta ophthalmologica 98 (5), e639-e648, 2020 | 126 | 2020 |
Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report JC Yam, XJ Zhang, Y Zhang, YM Wang, SM Tang, FF Li, KW Kam, ST Ko, ... Ophthalmology 129 (3), 308-321, 2022 | 123 | 2022 |
Update on the treatment of diabetic retinopathy JCS Yam, AKH Kwok Hong Kong Medical Journal 13 (1), 46, 2007 | 105 | 2007 |
A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study CY Cheung, AR Ran, S Wang, VTT Chan, K Sham, S Hilal, ... The Lancet Digital Health 4 (11), e806-e815, 2022 | 102 | 2022 |
Advances of optical coherence tomography in myopia and pathologic myopia DSC Ng, CYL Cheung, FO Luk, S Mohamed, ME Brelen, JCS Yam, ... Eye 30 (7), 901-916, 2016 | 101 | 2016 |
Low-concentration atropine eye drops for myopia progression FF Li, JC Yam The Asia-Pacific Journal of Ophthalmology 8 (5), 360-365, 2019 | 88 | 2019 |
Clinical characteristics and transmission of COVID-19 in children and youths during 3 waves of outbreaks in Hong Kong GT Chua, JSC Wong, I Lam, PPK Ho, WH Chan, FYS Yau, JSR Duque, ... JAMA network open 4 (5), e218824-e218824, 2021 | 87 | 2021 |
Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression study FF Li, Y Zhang, X Zhang, BHK Yip, SM Tang, KW Kam, AL Young, ... Ophthalmology 128 (8), 1180-1187, 2021 | 86 | 2021 |
Corneal collagen cross-linking demarcation line depth assessed by Visante OCT after CXL for keratoconus and corneal ectasia JCS Yam, CWN Chan, ACK Cheng Journal of Refractive Surgery 28 (7), 475-481, 2012 | 84 | 2012 |
Epidemiology of myopia and prevention of myopia progression in children in East Asia: a review CY Mak, JCS Yam, LJ Chen, SM Lee, AL Young Hong Kong Medical Journal 24 (6), 602, 2018 | 83 | 2018 |
Bilateral deepening of upper lid sulcus from topical bimatoprost therapy JCS Yam, NSY Yuen, CWN Chan Journal of ocular pharmacology and therapeutics 25 (5), 471-472, 2009 | 75 | 2009 |